GLP-1 peptides can degrade if shipped warm, so refrigerated, included shipping is a real plus — not just a freebie. Here’s what each provider states.
Provider data may change · advertised price · last checked 2026-06-25 · availability may vary by state and prescribing basis.
| Provider | Shipping | Cold-chain stated? | Provenance |
|---|---|---|---|
| Fifty 410 | Free overnight/2-day | Yes, refrigerated (stated) | primary |
| NexLife | Free (confirmed) | Not specified | primary |
| Henry Meds | Included (stated) | Not specified | secondary |
| Mochi Health | Not confirmed | Not disclosed | secondary |
Ask any provider whether shipping is refrigerated and how delays are handled — see cold-chain shipping & storage.
The FDA resolved the tirzepatide (Dec 2024) and semaglutide (Feb 2025) shortages, and wind-down deadlines passed in 2025. On Apr 30, 2026 the FDA proposed excluding these drugs from the 503B bulks list (comment closed Jun 29, 2026). Patient-specific 503A compounding continues only narrowly, and cost alone is not a clinical need. Full regulatory status →
Compounded semaglutide and tirzepatide are not FDA-approved and are not the same as Wegovy, Ozempic, Zepbound, or Mounjaro. The FDA does not review compounded drugs for safety, effectiveness, or quality before marketing. Primary source: FDA — Human Drug Compounding.